Orthofix (Nasdaq:OFIX) recorded first-quarter financial results that came in ahead of the consensus forecast on Wall Street. The Lewisville, Texas-based orthopedic implant company posted losses of $4.5 million, or 22¢ per share, on sales of $106.4 million for the three months ended March 31, 2022, for a slight bottom-line gain closer to breakeven on sales […]
Implants
The cloud is transforming medtech: Amazon, Microsoft, Google, J&J, Philips and GE Healthcare leaders explain
Leaders in medtech and cloud computing discuss payoffs and potential in device connectivity, product development and cross-industry partnerships. If knowledge is power, that power comes from a steady stream of information, and we know there’s no shortage of that in healthcare. The challenge has long been how to capture that information, store it, analyze it […]
NuVasive beats The Street in Q1, raises 2022 guidance
NuVasive (Nasdaq:NUVA) shares ticked up today on first-quarter results that came in ahead of the consensus forecast. The San Diego–based spine surgery tech company posted profits of $19.2 million, or 35¢ per share, on sales of $290.8 million for the three months ended March 31, 2022, for a massive bottom-line gain out of the red […]
Staar Surgical rises on Street-beating Q1, Evo lens shipments remain ‘robust’
Staar Surgical (Nasdaq:STAA) shares got a boost this morning on first-quarter results that topped the consensus forecast. STAA shares were up 11% at $70.91 per share as the market opened today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was down 0.4%. However, Staar shares were down […]
Orthofix wins FDA PMA for bone growth stimulation device
Orthofix (Nasdaq:OFIX) announced today that it received FDA premarket approval (PMA) for its AccelStim bone healing therapy device. Lewisville, Texas-based Orthofix designed the AccelStim device to provide a safe and effective nonsurgical treatment for indicated fresh fractures and for fractures that have not healed (nonunions). According to a news release, the device generates a low-intensity […]
SeaSpine rises on Q1 earnings, increased 2022 revenue outlook
SeaSpine (Nasdaq:SPNE) shares rose today on first-quarter results that were mixed compared to the consensus forecast. The Carlsbad, California–based spine treatment tech company posted losses of $16.6 million, or 45¢ per share, on sales of $50.7 million for the three months ended March 31, 2022, for a 30% bottom-line slide further into the red on […]
Zimmer Biomet rises on Street-beating Q1, raised guidance
Zimmer Biomet (NYSE:ZBH) shares ticked up today on first-quarter results ahead of the consensus forecast, with ZB upping its 2022 forecast. The Warsaw, Indiana–based company posted profits of $14.2 million, or 7¢ per share, on sales of $1.7 billion for the three months ended March 31, 2022, for a 92.8% bottom-line slide on sales growth […]
Medtronic investigates HVAD pump welds after patient deaths
Medtronic (NYSE:MDT) is investigating a new problem with its HeartWare Ventricular Assist Device (HVAD) nearly one year after halting sales and new implantations of the device. Fridley, Minnesota-based Medtronic said it received three complaints of suspected pump thrombosis in patients. Two of the patients died after their heart pumps were exchanged. Medtronic found a malfunction when inspecting […]
18 of the world’s most innovative medical technologies
Judges this week are voting for the most innovative medical technologies among the nominees for the 2022 Prix Galien International Awards. The Prix Galien International Awards highlight the most innovative technologies in the life sciences industry. The New York-based Galien Foundation presents the international award to eligible nominees that have received a Prix Galien award […]
FDA approves Biotronik’s programmer for implanted cardiac rhythm management devices
Biotronik announced today that the FDA approved its Renamic Neo programmer for implanted cardiac rhythm management devices. Lake Oswego, Oregon-based Biotronik designed its Renamic Neo programmer for implanted devices, including ICDs, pacemakers and implantable cardiac monitors. According to a news release, Renamic Neo offers LifeSupport for clinicians to share the programmer screen with or grant […]
Medtronic warns on some Percept neurostimulators
Medtronic (NYSE:MDT) has issued an urgent field safety notice in Europe regarding its Percept PC implantable neurostimulator (INS). The letter informs users that, in rare instances (0.044%), the Percept PC INS Model B35200 can’t communicate with the clinician programmer and/or the patient programmer system (HH90 Handset and TM91 Communicator). According to the safety notice, in […]